United States Rheumatoid Arthritis Therapeutics Market Size Growth Report
The United States Rheumatoid Arthritis (RA) therapeutics market refers to the healthcare segment that focuses on creating, manufacturing, selling drugs that treat rheumatoid arthritis, an ongoing autoimmune disease. The treatments for rheumatoid arthritis use biologic agents, disease-modifying antirheumatic drugs, JAK inhibitors, and biosimilars to reduce inflammation and prevent joint damage, which increases patient happiness. The market will experience substantial expansion because rheumatoid arthritis cases increase, together with the elderly population growth and the rising adoption of innovative biologic medicines.